Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian Cancer
Clinical trial NCT05044871 · COMPLETED
Trial details
- NCT number
- NCT05044871
- Sponsor
- Tongji Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-22
- Primary completion
- 2025-02-17
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.